These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24066374)

  • 1. [CIRS-AINS special: particle contamination after drawing drugs - a relevant problem with a solution].
    Günther W; Hahnenkamp C; Rhaiem T; Schleppers A; St Pierre M
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(4-5):352-5. PubMed ID: 24066374
    [No Abstract]   [Full Text] [Related]  

  • 2. Industry perspective on the medical risk of visible particles in injectable drug products.
    Bukofzer S; Ayres J; Chavez A; Devera M; Miller J; Ross D; Shabushnig J; Vargo S; Watson H; Watson R
    PDA J Pharm Sci Technol; 2015; 69(1):123-39. PubMed ID: 25691720
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous therapy is not being carried out effectively.
    Scott H
    Br J Nurs; 2003 Nov 13-26; 12(20):1172. PubMed ID: 14685121
    [No Abstract]   [Full Text] [Related]  

  • 4. Practice guidelines should be endorsed.
    Hesketh N
    Br J Nurs; 2003 Nov 27-Dec 10; 12(21):1246. PubMed ID: 14700032
    [No Abstract]   [Full Text] [Related]  

  • 5. Practice guidelines should be endorsed.
    Howell E
    Br J Nurs; 2003 Nov 27-Dec 10; 12(21):1246. PubMed ID: 14700031
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of in-Line Filters to Completely Remove Particulate Contamination During a Pediatric Multidrug Infusion Protocol.
    Perez M; Décaudin B; Abou Chahla W; Nelken B; Storme L; Masse M; Barthélémy C; Lebuffe G; Odou P
    Sci Rep; 2018 May; 8(1):7714. PubMed ID: 29769547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative estimation of particulate matter in pharmaceutical preparations intended for intravenous administration.
    Bikhazi AB; Shiatis JA; Haddad AF
    J Pharm Sci; 1977 Feb; 66(2):181-6. PubMed ID: 839413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particulate and microbial contamination in in-use admixed intravenous infusions.
    Yorioka K; Oie S; Oomaki M; Imamura A; Kamiya A
    Biol Pharm Bull; 2006 Nov; 29(11):2321-3. PubMed ID: 17077539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Particulate contaminants of intravenous medications and infusions.
    Backhouse CM; Ball PR; Booth S; Kelshaw MA; Potter SR; McCollum CN
    J Pharm Pharmacol; 1987 Apr; 39(4):241-5. PubMed ID: 2884285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of intravenous drug administration by preregistration house officers.
    Teahon K; Bateman DN
    BMJ; 1993 Sep; 307(6904):605-6. PubMed ID: 8401018
    [No Abstract]   [Full Text] [Related]  

  • 11. Overview of the International Conference on Particle Detection, Metrology, and Control.
    Knapp JZ; Barber TA
    J Parenter Sci Technol; 1990; 44(5):257-63. PubMed ID: 1979082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Particulate Matter in Liquid-Finished Dosage Forms.
    Duchek J; Havasi B
    PDA J Pharm Sci Technol; 2018; 72(6):608-625. PubMed ID: 29853612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visible Particulate Contamination Control for Injectable Products: A Life-Cycle Approach.
    Langille SE
    PDA J Pharm Sci Technol; 2020; 74(3):359-366. PubMed ID: 31732691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Microfilters within the scope of infusion therapy--possibilities and problems in retention of microbial and particle contaminants].
    Bach A; Böttiger BW
    Zentralbl Chir; 1994; 119(4):268-75. PubMed ID: 8203178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particulate Generation Mechanisms during Bulk Filling and Mitigation via New Glass Vial.
    Timmons CL; Liu CY; Merkle S
    PDA J Pharm Sci Technol; 2017; 71(5):379-392. PubMed ID: 28512178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Needlestick-prevention devices.
    Health Devices; 1994; 23(8-9):316-69. PubMed ID: 7860323
    [No Abstract]   [Full Text] [Related]  

  • 17. Towards IV drug standardization in critical care.
    Keeling P; Scales K; Keeling S; Borthwick M
    Br J Nurs; 2010 Oct 28-Nov 10; 19(19):S30-3. PubMed ID: 21042245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous drug preparation: the infection risks.
    Curran E
    Br J Nurs; 2011 Jul 28-Aug 4; 20(14):S4, S6-8. PubMed ID: 21841666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary report: biosafety analysis of one-way backflow valves for multiple patient use of low osmolar intravenous contrast solution.
    Can Commun Dis Rep; 1996 Feb; 22(4):28-31. PubMed ID: 9053058
    [No Abstract]   [Full Text] [Related]  

  • 20. [Problems of microbial contamination and sterility when administering drugs intravenously].
    Opulchenova G; Gencheva G
    Khirurgiia (Sofiia); 1983; 36(5):471-4. PubMed ID: 6366342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.